[vc_row][vc_column offset=”vc_col-lg-offset-1 vc_col-lg-10″][vc_column_text]
In the News
[/vc_column_text][/vc_column][/vc_row]
-
September 15, 2023
‘A wonderful feeling’: Hudson man with aggressive brain tumor defies odds
Akron Beacon Journal | Derek Kreider
-
July 13, 2021
Dr. Lou Vaickus and Dr. Jing Watnick Share Insights on VT1021 Data Presented at SITC 2020
PharmaShots | Lou Vaickus and Jing Watnick
-
June 01, 2021
Cancer Patients Can Not Afford To Put Their Struggle on Hold
Pharmaceutical Executive | Jing Watnick
-
May 05, 2021
What immuno-oncology research can tell us about Covid-19
Drug Therapy Review | Jing Watnick
-
August 07, 2020
The BioSpace interview on Vigeo’s Tumor Microenvironment Platform Expands Indications and Combo Therapy Possibilities
BioSpace.com | By Gail Dutton
-
March 17, 2020
Biotech Strategy Blog – Helping more patients respond to immunotherapy (an interview with Sally Church)
Thoughtful interview by Sally Church and Biotech Strategy Blog with Vigeo CEO Jing Watnick and co-founder Randy Watnick